AbbVie Inc Unclassified
FDA Approved Drugs
AbbVie Inc Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 19
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Company
AbbVie Inc Unclassified
Country
U.S.A
Website
Social Profiles
Company Snapshot
AbbVie Inc Unclassified
1 North Waukegan Road North Chicago, IL 60064
U.S.A
www.abbvie.com/ abbviecontractmfg@abbvie.com View on MapFDA Approved Drug Records ( 19 records )
Drug Name
BIAXIN XL
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Active Ingredient
CLARITHROMYCIN
Application Number
50697
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BIAXIN XL
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
CLARITHROMYCIN
Application Number
50697
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CREON
Product Number
1
Dosage Form
-
Strength
30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Approval Date
-
Active Ingredient
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Application Number
20725
Product Number
1
Dosage Form
-
Strength
30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CREON
Product Number
2
Dosage Form
-
Strength
60,000USP UNITS;12,000USP UNITS;38,000USP UNITS
Approval Date
-
Active Ingredient
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Application Number
20725
Product Number
2
Dosage Form
-
Strength
60,000USP UNITS;12,000USP UNITS;38,000USP UNITS
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CREON
Product Number
3
Dosage Form
-
Strength
120,000USP UNITS;24,000USP UNITS;76,000USP UNITS
Approval Date
-
Active Ingredient
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Application Number
20725
Product Number
3
Dosage Form
-
Strength
120,000USP UNITS;24,000USP UNITS;76,000USP UNITS
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CREON
Product Number
4
Dosage Form
-
Strength
15,000USP UNITS;3,000USP UNITS;9,500USP UNITS
Approval Date
-
Active Ingredient
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Application Number
20725
Product Number
4
Dosage Form
-
Strength
15,000USP UNITS;3,000USP UNITS;9,500USP UNITS
Approval Date
-
Regulatory Status
Unclassified
Drug Name
CREON
Product Number
5
Dosage Form
-
Strength
180,000USP UNITS;36,000USP UNITS;114,000USP UNITS
Approval Date
-
Active Ingredient
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Application Number
20725
Product Number
5
Dosage Form
-
Strength
180,000USP UNITS;36,000USP UNITS;114,000USP UNITS
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DECNUPAZ
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
-
Active Ingredient
PIVEKIMAB SUNIRINE-PVZY
Application Number
761460
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DEPAKOTE ER
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Active Ingredient
DIVALPROEX SODIUM
Application Number
22267
Product Number
1
Dosage Form
-
Strength
250MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DEPAKOTE ER
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
DIVALPROEX SODIUM
Application Number
22267
Product Number
2
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMRELIS
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Active Ingredient
TELISOTUZUMAB VEDOTIN-TLLV
Application Number
761384
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMRELIS
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
TELISOTUZUMAB VEDOTIN-TLLV
Application Number
761384
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HUMIRA
Product Number
1
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Active Ingredient
ADALIMUMAB
Application Number
125057
Product Number
1
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HUMIRA
Product Number
2
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Active Ingredient
ADALIMUMAB
Application Number
125057
Product Number
2
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LUPRON DEPOT
Product Number
2
Dosage Form
-
Strength
3.75MG
Approval Date
-
Active Ingredient
LEUPROLIDE ACETATE
Application Number
19943
Product Number
2
Dosage Form
-
Strength
3.75MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SKYRIZI
Product Number
1
Dosage Form
-
Strength
75MG/0.83ML
Approval Date
-
Active Ingredient
RISANKIZUMAB-RZAA
Application Number
761105
Product Number
1
Dosage Form
-
Strength
75MG/0.83ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SKYRIZI
Product Number
2
Dosage Form
-
Strength
150MG/ML
Approval Date
-
Active Ingredient
RISANKIZUMAB-RZAA
Application Number
761105
Product Number
2
Dosage Form
-
Strength
150MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SKYRIZI
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
-
Active Ingredient
RISANKIZUMAB-RZAA
Application Number
761262
Product Number
1
Dosage Form
-
Strength
600MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SURVANTA
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
-
Active Ingredient
BERACTANT
Application Number
20032
Product Number
1
Dosage Form
-
Strength
25MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Status Breakdown
19 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
BIAXIN XL
Application Number
50697
Product Number
1
Active Ingredient
CLARITHROMYCIN
Dosage Form
-
Strength
250MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.